Radiation Oncology Physician Scientist; Tenure Track (Assistant to Associate Professor)

Rutgers University

Recruitment/Posting Title Radiation Oncology Physician Scientist; Tenure Track (Assistant to Associate Professor)

Department Cancer Institute of New Jersey

Salary Details A minimum of $402,703 for assistant professor. Salary commensurate with rank

Offer Information

The final salary offer may be determined by several factors, including, but not limited to, the candidate’s qualifications, experience, and expertise, and availability of department or grant funds to support the position. We also take into consideration market benchmarks, if and when appropriate, and internal equity to ensure fair compensation relative to the university’s broader compensation structure. We are committed to offering competitive and flexible compensation packages to attract and retain top talent.

Benefits

Rutgers offers a comprehensive benefits package to eligible employees, based on position, which includes:

  • Medical, prescription drug, and dental coverage
  • Paid vacation, holidays, and various leave programs
  • Competitive retirement benefits, including defined contribution plans and voluntary tax-deferred savings options
  • Employee and dependent educational benefits
  • Life insurance coverage
  • Employee discounts programs

For detailed information on benefits and eligibility, please visit: http://uhr.rutgers.edu/benefits/benefits-overview.

Posting Summary

The Department of Radiation Oncology at Robert Wood Johnson Medical School and Rutgers Cancer Institute is seeking applications for a physician-scientist faculty position. This is a tenure track position at the Assistant or Associate Professor level that requires excellence in clinical practice and demonstrated accomplishments in scientific research. In addition to education, clinical, and research responsibilities, this faculty position will collaborate closely with other Rutgers Cancer Institute programs, accessing state-of-the-art resources and integrated cancer care opportunities.

The Rutgers Cancer Institute oncology service line is the largest academic health care system in NJ with a service area covering nine counties and a population of five million people. The Institute is the only NCI-designated Comprehensive Cancer Center in the state of NJ, and operates the recently completed Jack and Sheryl Morris Cancer Center- a 12 story, 520,000 square foot freestanding cancer hospital in New Brunswick, NJ. The department leads clinical and translational programs in MR-Linac based adaptive radiotherapy, IMRT/IGRT, SBRT, Brachytherapy, GKRS, Proton therapy, and Radiopharmaceutical therapy.

Candidates must have and MD/DO degree, be board certified/eligible in Radiation Oncology, and be eligible for a NJ Medical License. Candidates should also possess a strong publication record and the capacity to obtain extramural research funding. For more information about our department, please visit: https://sites.rutgers.edu/cinj-radiation-oncology/. For additional information or to apply please contact:cinjcareers@rutgers.edu.

Position Status Full Time

Posting Number 25FA0800

Posting Open Date 08/19/2025

Posting Close Date 10/12/2026

Minimum Education and Experience

  • MD/DO
  • Board certified/eligible in Radiation Oncology
  • Active NJML or qualify for NJML
  • Strong publication record and the capacity to obtain extramural research funding.

Rank will be commensurate with experience.

Certifications/Licenses

Required Knowledge, Skills, and Abilities

Preferred Qualifications

Equipment Utilized

Physical Demands and Work Environment

Overview

RBHS

New Jersey’s premier academic health center, Rutgers Biomedical and Health Sciences (RBHS) takes an integrated approach to educating students, providing clinical care, and conducting research, all with the goal of improving human health. Aligned with Rutgers University–New Brunswick and collaborating university wide, RBHS includes eight schools, a behavioral health network, and five centers and institutes that focus on cancer treatment and research, neuroscience, advanced biotechnology and medicine, environmental and occupational health, and health care policy and aging research. Our renowned faculty are teachers, health researchers and providers, and scientists with unparalleled experience who advance medical innovation and provide patient care informed by the latest research findings. We offer an outstanding education and training in medicine, dentistry, pharmacy, public health, nursing, biomedical research, and the full spectrum of allied health careers. An important mission of RBHS is to promote the careers of faculty, staff, and learners. Through this community of healers, scientists, and scholars, Rutgers is equipped as never before to transform lives.

Rutgers Robert Wood Johnson Medical School

As one of the nation’s comprehensive medical schools, Rutgers Robert Wood Johnson Medical School (RWJMS) is dedicated to pursuing excellence in education, research, healthcare delivery, and the promotion of community health. In cooperation with Robert Wood Johnson University Hospital, the medical school’s principal affiliate, they comprise New Jersey’s premier academic medical center. In addition, RWJMS has 34 other hospital affiliates and ambulatory care sites throughout the region. RWJMS encompasses 20 basic science and clinical departments and hosts centers and institutes, described below. The medical school maintains undergraduate, graduate, and postgraduate educational programs for more than 1,500 students on its campuses in New Brunswick and Piscataway. It provides continuing education courses for healthcare professionals and community education programs. Previously an academic unit of the University of Medicine and Dentistry of New Jersey, RWJMS became part of Rutgers, The State University of New Jersey, as part of the New Jersey Medical and Health Sciences Education Restructuring Act, on July 1, 2013.

Rutgers Cancer Institute

As New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute, in partnership with RWJBarnabas Health, is a leader in cancer research, treatment, prevention, and education. Rutgers Cancer Institute offers world-class cancer care, providing patients with the most advanced treatment options through an integrated cancer care network, including clinical trials, immunotherapy, precision medicine, complex surgical procedures, and sophisticated radiation therapy techniques. Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, are one of only two programs in the state to offer blood and marrow transplantations and CAR T-cell therapy. It also houses the state’s only hospital-based proton therapy center. Rutgers Cancer Institute is a cornerstone of New Jersey’s premier academic health center, Rutgers Biomedical and Health Sciences (RBHS).

Construction is currently underway for a new $750 million state-of-the-art Cancer Center adjacent to the current Rutgers Cancer Institute facility and Robert Wood Johnson University Hospital. The 510,000 square foot Jack and Sheryl Morris Cancer Center will be the state’s first free-standing cancer hospital. It will feature outpatient and inpatient clinical space—including 84 infusion bays, 74 exam rooms, and 96 inpatient beds. This is in addition to state-of-the-art laboratories where critical scientific investigation will be amplified, enabling physician-scientists to translate findings directly to patients. The Jack and Sheryl Morris Cancer Center will also have the capacity to offer wellness and education resources all in one location. Learn more about this incredible facility at www.cinj.org/jackandsherylmorriscancercenter.

Rutgers Cancer Institute is home to nearly 250 internationally recognized physicians and researchers. The long-standing relationship with their NCI Research Consortium Partner Princeton University was recently leveraged to establish the Ludwig Cancer Research Princeton Branch with several faculty as founding members and leaders of the Branch. Their work on cancer metabolism, not only through the new Ludwig Branch but also through the Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute, will accelerate and translate laboratory discoveries into clinical treatments through more effective and efficiently designed clinical trials.

The Rutgers Cancer Institute’s Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence is an institute at the intersection of oncologic immunology and metabolism that seeks to increase research that leads to new therapies for patients; develop cutting-edge facilities to test new interventions; and facilitate commercial and university collaborations. This includes discovery and production of novel cell therapy constructs via an institutional good manufactory practices (GMP) facility. Visit Center of Excellence in Cancer Immunology and Metabolism.

Rutgers Cancer Institute is committed to retaining, recruiting, and developing outstanding faculty, staff, and students, including those traditionally underrepresented in medicine in faculty, staff, and student bodies. It aspires to be an agent of progress in advancing equality and justice while improving healthcare access and reducing healthcare disparities. Visit us here.

More information on our community here.

Statement

Rutgers Cancer Institute, the state’s only NCI-designated Comprehensive Cancer Center and RWJBarnabas Health, the state’s largest health care delivery system partner to deliver high-quality and sophisticated oncology care to patients close to home. This integrated cancer care model combines the strength of both entities, offering access to the most advanced diagnostic and treatment options for adult and pediatric cancer patients, including clinical trials, immunotherapy, proton therapy, precision medicine, CAR T-cell therapy and cardio-oncology. Through the above mentioned partnership and an academic appointment at Rutgers, The State University of New Jersey, unique opportunities exist for collaborations between clinical and research programs, including clinical trials research, cancer chemoprevention, clinical and basic pharmacology, and Phase 1 clinical trials.

Mission

To accelerate scientific discovery focused on understanding cancer, innovating cancer treatment, and improving cancer prevention; to provide outstanding, novel, and compassionate patient care; to provide evidence-based and culturally informed education to physicians, nurses, researchers, staff, and the community; and to achieve cancer health equity in our state through outreach to and engagement of our extraordinarily diverse communities

Vision

Through our science, our evidence-based actions, our openness, and our respect for those we serve, we will advance cancer-focused research worldwide and reduce the burden of cancer in our catchment area. By engaging with and empowering our exceptionally diverse populations, and addressing their questions and fears, we will engender hope for cancer patients and their families and play a critical role in strengthening the fabric of our communities by gaining and protecting their trust and providing access to the outstanding oncology care each person deserves.

Core Values

  • Curiosity and Discovery: encouraging an environment of continuous inquiry, creativity, and innovation to generate new knowledge
  • Integrity: earning the trust of those we serve and each other through honesty, transparency, accountability, and continuous reflection
  • Collaboration: approaching all opportunities with an understanding that together we are better and can achieve more; promoting and maintaining an environment of teamwork and shared knowledge
  • Cultivating Diversity: making conscientious efforts in all we do to ensure that our leadership, scientists, clinicians, supporting staff, and trainees reflect the rich diversity of the state of New Jersey and the patient populations and communities we serve
  • Respect and Caring: consistently demonstrating caring, compassion, and respect through our words and actions
  • Perseverance: maintaining an unwavering commitment to our mission; embracing change, overcoming obstacles, and creating and recreating the path to achieve our goals

Special Instructions to Applicants

Applicants should submit a CV, a cover letter detailing how the candidate’s work will contribute to the Rutgers Cancer Institute Mission, a research statement, and list 3 references with contact information or upload reference letters.

Quick Link to Posting https://jobs.rutgers.edu/postings/258347

Campus Rutgers Biomedical and Health Sciences (RBHS)

Home Location Campus Downtown New Brunswick

City New Brunswick

State NJ

Location Details

Read Full Description
Confirmed 22 hours ago. Posted 30+ days ago.

Discover Similar Jobs

Suggested Articles